Companies

Dr Reddy’s heart drug generic in US

Our Bureau Hyderabad | Updated on January 17, 2018 Published on August 29, 2016

Pharma major Dr Reddy’s Laboratories has launched Nitroglycerin sublingual tablets, a therapeutic equivalent generic version of Nitrostat (Nitroglycerin) sublingual tablets, in the US market. The drug indicated for preventing or relieving a sudden attack of angina (chest pain).

The Nitrostat (Nitroglycerin) sublingual tablet brand had the US sales of approximately $108 million MAT for the 12 months ending in March 2016 according to the IMS Health, said a release from the company. Dr Reddy’s scrip gained 0.28 per cent on the Bombay Stock Exchange on Monday to close at ₹3048.40.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on August 29, 2016
This article is closed for comments.
Please Email the Editor